跳至主要内容
临床试验/NCT04736667
NCT04736667招募中不适用

Mitral Valve Screening Survey (MVSS)

Medstar Health Research Institute16 个研究点 分布在 2 个国家目标入组 1,000 人开始时间: 2021年8月6日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
16
主要终点
All-cause mortality

研究概览

简要总结

This study aims to examine the clinical profile/anatomical characteristics and natural history of patients who subsequently fail screening for transcatheter mitral valve intervention (TMVI).

详细描述

Numerous transcatheter mitral valve interventions have emerged as a treatment option for patients with mitral valve disease. Development of transcatheter mitral valve repair (TMVr) and transcatheter mitral valve replacement (TMVR) continues to progress with ongoing rigorous clinical trials of several experimental devices. However, despite being referred for TMVI, most patients do not pass stringent screening criteria for these investigational devices and are not offered TMVI.

In this prospective multicenter registry, baseline demographics, anatomical/imaging characteristics, and clinical outcomes of patients who fail screening for TMVI will be prospectively collected into a registry database.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject failed screening for TMVI

排除标准

  • Under 18 years of age
  • Subject unable or unwilling to give informed consent
  • Subject proceeded with TMVI.

结局指标

主要结局

All-cause mortality

时间窗: 1 year

次要结局

  • Reason for screen failure(Baseline)
  • All-cause mortality(30 days, 1 year, and annually up to 5 years)
  • Hospitalizations(30 days, 1 year, and annually up to 5 years)
  • Mitral intervention(30 days, 1 year, and annually up to 5 years)

研究者

发起方
Medstar Health Research Institute
申办方类型
Other
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验